Un estudio liderado por un equipo de investigación del IISPV, la URV, el Hospital Universitario Joan XXIII de Tarragona y CIBERDEM junto con otras instituciones colaboradoras (IRB-UB y CRG-UPF) ha pe...
Read morePolyphenols in the foods that we eat can prevent inflammation in older people, since they alter the intestinal microbiota and induce the production of the indole 3-propionic acid (IPA), a metabolite d...
Read moreThe funding is for Oryzon’s project entitled “Development of new treatments against Acute Myeloid Leukemia (AML) using iadademstat,an epigenetic drug” with a duration of 30 months (January 2022 ...
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read moreUn estudio coordinado por investigadores del Consejo Superior de Investigaciones Científicas (CSIC) ha evaluado el efecto del trasplante de microbiota intestinal en individuos con síndrome metabóli...
Read moreScientists at IRB Barcelona led by ICREA researcher Dr. Raúl Méndez, head of the Translational Control of Cell Cycle and Differentiation lab, have described the cellular mechanism that coordinates t...
Read moreEn un artículo publicado en The International Journal of Epidemiology, investigadores de la Universidad Autónoma de Madrid (UAM), el Parc Sanitari Sant Joan de Déu (Barcelona) y el CIBER de Salud M...
Read moreInvestigadores del Grupo Clínico Vinculado al CIBERER liderado por José Antonio López-Escámez en la Universidad de Granada y el Instituto Biosanitario de Granada (ibs.GRANADA) han identificado un ...
Read morePresented by Ana Oaknin, Principal Investigator of VHIO’s Gynecological Malignancies Group, during this week’s American Society of Clinical Oncology’s (ASCO) Annual Meeting, 03 – 07 June 2022,...
Read moreCo-authored by VHIO investigators, primary results from the multicenter TROPiCS-02 study of novel antibody-drug conjugate (ADC) sacituzumab govitecan in patients with hormone receptor-positive/HER2...
Read moreLa Unidad de Investigación de Terapia Molecular (UITM)-CaixaResearch tiene un papel destacado en el desarrollo de nuevos fármacos. Durante el Congreso Anual de la Sociedad Americana de Oncología Cl...
Read moreSelected by the American Society of Clinical Oncology (ASCO) to first outing as an oral presentation*during its Annual Meeting, 03 – 07 June 2022, Chicago (IL, USA), results of a study led by César...
Read more